Hot Stocks
| ShowHide Related Items >><< - 05/11/23
- UFP Technologies CFO Lataille sells 7,354 common shares
- 05/02/23
- Shares of LendingTree fall 28% after Q1 results and lowered guidance
- 03/29/23
- LendingTree announces 13% workforce reduction plan
- 03/06/23
- LendingTree repurchases $190M of Convertible Senior Notes due 2025
- 02/01/23
- LendingTree CEO buys $705.7K in common stock
- 05/08/23
- Tredegar falls -14.3%
- 01/09/23
- Tredegar chairman of the board John Gottwald to retire
- 05/04/23
- Schrodinger backs FY23 financial guidance
- 03/22/23
- Schrodinger reports inducement grants under Nasdaq Listing Rule
- 02/28/23
- Schrodinger sees FY23 software revenue growth 13%-17%
- 01/20/23
- Schrodinger reports inducement grants under Nasdaq Listing Rule
- 03/09/23
- Moelis appoints Elizabeth Crain to Vice Chair, Kate Pilcher Ciafone to COO
- 03/07/23
- Moelis exec Mahmoodzadegan sells 23,323 class A shares
- 02/13/23
- Moelis exec sold $4.4M in common stock
- 01/10/23
- Inogen achieves regulatory milestones to support portable oxygen products
- 05/03/23
- Faro Technologies CEO Michael Burger to retire, Yuval Wasserman interim CEO
- 01/30/23
- Douglas Elliman promotes Deva Roberts to general counsel
- 05/01/23
- California Resources names Manuela Molina CFO
- 02/24/23
- CRC CEO Mark McFarland to switch roles, Francisco Leon to succeed
- 02/24/23
- California Resources sees FY23 capital program $200M-$245M
- 02/24/23
- California Resources sees Q1 capital program $57M-$69M
- 12/08/22
- CarGurus announces $250M share repurchase program
- 05/18/23
- Cara announces NICE recommends Kapruvia for CKD-associated pruritus treatment
- 03/10/23
- Cara Therapeutics says it does not hold cash deposits, securities at SVB
- 03/06/23
- Cara sees cash, cash equivalents sufficient to fund ops into at least 1H24
- 02/08/23
- Cara Therapeutics announces results from Phase 2 trial of oral Difelikefalin
- 06/02/23
- Big Lots rises 20.5%
- 06/02/23
- Big Lots rises 23.2%
- 06/02/23
- Big Lots rises 15.1%
- 05/30/23
- Big Lots falls -11.8%
- 05/09/23
- Artisan Partners reports April AUM $138.4B
- 04/12/23
- Artisan Partners reports preliminary AUM $138.5B as of March 31
- 03/09/23
- Artisan Partners reports February AUM $134.8B
- 01/11/23
- Artisan Partners preliminary AUM as of December 31 $127.9B
- 03/06/23 Goldman Sachs
- Artisan Partners downgraded to Sell at Goldman on performance challenges
- 03/06/23 Goldman Sachs
- Artisan Partners downgraded to Sell from Neutral at Goldman Sachs
- 01/31/23 RBC Capital
- Artisan Partners price target raised to $39 from $35 at RBC Capital
- 10/18/22 Credit Suisse
- Artisan Partners initiated with a Neutral at Credit Suisse
- 05/19/23 Stifel
- California Resources price target lowered to $50 from $52 at Stifel
- 05/19/23 Mizuho
- California Resources price target lowered to $52 from $54 at Mizuho
- 03/30/23 Stifel
- California Resources price target lowered to $52 from $64 at Stifel
- 03/10/23 Mizuho
- California Resources price target lowered to $54 from $59 at Mizuho
- 05/12/23 Oppenheimer
- CarGurus price target raised to $24 from $21 at Oppenheimer
- 05/10/23 DA Davidson
- CarGurus price target raised to $20 from $18 at DA Davidson
- 03/01/23 Raymond James
- CarGurus price target raised to $20 from $16 at Raymond James
- 03/01/23 Citi
- CarGurus price target raised to $18 from $14 at Citi
- 04/12/23 Morgan Stanley
- Moelis price target lowered to $29 from $30 at Morgan Stanley
- 01/10/23 Goldman Sachs
- Moelis downgraded to Sell from Neutral at Goldman Sachs
- 01/02/23 Keefe Bruyette
- Moelis transferred with Underperform rating at Keefe Bruyette
- 01/02/23 Keefe Bruyette
- Evercore upgraded to Outperform from Market Perform at Keefe Bruyette
- 05/25/23 Mizuho
- Phillips Edison price target lowered to $30 from $35 at Mizuho
- 05/23/23 Wells Fargo
- Phillips Edison initiated with an Equal Weight at Wells Fargo
- 03/21/23 Goldman Sachs
- Phillips Edison resumed with a Buy at Goldman Sachs
- 03/01/23 Mizuho
- Phillips Edison price target raised to $35 from $33 at Mizuho
- 05/08/23 Citi
- Schrodinger price target lowered to $50 from $52 at Citi
- 05/05/23 Piper Sandler
- Schrodinger assumed with an Overweight at Piper Sandler
- 03/01/23 BMO Capital
- Schrodinger price target lowered to $78 from $83 at BMO Capital
- 01/31/23 Citi
- Schrodinger price target raised to $51 from $48 at Citi
- 05/03/23 Lake Street
- UFP Technologies price target raised to $171 from $131 at Lake Street
- 03/08/23 Lake Street
- UFP Technologies price target raised to $131 from $124 at Lake Street
- 12/21/22 Lake Street
- UFP Technologies assumed with a Buy at Lake Street
- 06/22/22 Lake Street
- UFP Technologies initiated with a Buy at Lake Street
- 05/03/23 Truist
- LendingTree price target lowered to $27 from $42 at Truist
- 05/03/23 Northland
- LendingTree price target lowered to $24 from $35 at Northland
- 05/03/23 Susquehanna
- LendingTree price target lowered to $17 from $36 at Susquehanna
- 02/28/23 BofA
- LendingTree price target lowered to $43 from $53 at BofA
- 02/24/23 Needham
- Inogen price target lowered to $26 from $36 at Needham
- 01/17/23 William Blair
- Inogen downgraded to Market Perform from Outperform at William Blair
- 05/05/23 Baird
- Faro Technologies price target lowered to $21 from $32 at Baird
- 05/04/23 Craig-Hallum
- Faro Technologies price target lowered to $22 from $30 at Craig-Hallum
- 02/16/23 Needham
- Faro Technologies price target lowered to $35 from $39 at Needham
- 08/04/22 Needham
- Faro Technologies price target lowered to $40 from $50 at DA Davidson
- 05/16/23 BofA
- Cara Therapeutics price target lowered to $4 from $6 at BofA
- 05/16/23 H.C. Wainwright
- Cara Therapeutics price target lowered to $15 from $20 at H.C. Wainwright
- 03/07/23 BofA
- Cara Therapeutics downgraded to Underperform from Neutral at BofA
- 03/07/23 Needham
- Cara Therapeutics price target lowered to $22 from $26 at Needham
- 05/31/23 Goldman Sachs
- Big Lots price target lowered to $5 from $14 at Goldman Sachs
- 05/30/23 Deutsche Bank
- Big Lots price target lowered to $6 from $8 at Deutsche Bank
- 05/30/23 Loop Capital
- Big Lots price target lowered to $6 from $14 at Loop Capital
- 04/21/23 Piper Sandler
- Big Lots downgraded to Underweight from Neutral at Piper Sandler
- 05/02/23
- UFP Technologies reports Q1 EPS $1.27 vs 64c last year
- 03/07/23
- UFP Technologies reports Q4 EPS $1.10 vs 42c last year
- 05/02/23
- LendingTree cuts FY23 revenue view to $760M-$800M from $935M-$985M
- 05/02/23
- LendingTree sees Q2 revenue $190M-$200M, consensus $244.27M
- 05/02/23
- LendingTree reports Q1 adjusted EPS 25c, consensus (10c)
- 02/27/23
- LendingTree sees FY23 revenue $935M-$985M, consensus $985.62M
- 05/04/23
- Schrodinger reports Q1 EPS $1.75, consensus $1.31
- 02/28/23
- Schrodinger reports Q4 revenue $56.8M, consensus $47.43M
- 05/02/23
- Phillips Edison reports Q1 EPS 14c, consensus 11c
- 02/09/23
- Phillips Edison reports Q4 EPS 12c, consensus 8c
- 04/26/23
- Moelis reports Q1 EPS 5c, consensus 10c
- 02/08/23
- Moelis reports Q4 adjusted EPS 33c, consensus 33c
- 05/04/23
- Inogen reports Q1 EPS (88c), consensus (81c)
- 02/23/23
- Inogen reports Q4 EPS ($2.47) vs ($1.01) last year
- 01/10/23
- Inogen sees FY22 revenue $376.7M-$377.7M , consensus $378.6M
- 01/10/23
- Inogen sees Q4 revenue $$87.5M-$88.5M, consensus $89.55M
- 05/03/23
- Faro Technologies sees Q2 non-GAAP EPS (47c)-(22c), consensus (4c)
- 05/03/23
- Faro Technologies reports Q1 EPS (38c), consensus (13c)
- 02/15/23
- Faro Technologies sees Q1 adjusted EPS (22c)-(2c), consensus (9c)
- 02/15/23
- Faro Technologies reports Q4 adjusted EPS 38c, consensus 34c
- 03/09/23
- Douglas Elliman reports Q4 EPS (24c) vs. 26c last year
- 05/02/23
- California Resources reports Q1 adjusted EPS $2.63, consensus $1.96
- 02/24/23
- California Resources reports Q4 adjusted EPS $1.24, consensus $1.55
- 05/09/23
- CarGurus sees Q2 EPS 22c-25c, consensus 18c
- 05/09/23
- CarGurus reports Q1 EPS 26c, consensus 17c
- 02/28/23
- CarGurus sees Q1 EPS 17c-19c, consensus 12c
- 02/28/23
- CarGurus reports Q4 EPS 22c, consensus 10c
- 05/15/23
- Cara Therapeutics reports Q1 EPS (49c), consensus (52c)
- 03/06/23
- Cara Therapeutics reports Q4 EPS (56c), consensus (32c)
- 05/26/23
- Big Lots reports Q1 adjusted EPS ($3.40), consensus ($1.77)
- 03/02/23
- Big Lots reports Q4 adjusted EPS (28c), consensus (85c)
- 01/31/23
- Artisan Partners reports Q4 EPS 65c, consensus 62c
- 03/20/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/28/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/04/23
- Fly Intel: After-Hours Movers
- 02/28/23
- Fly Intel: After-Hours Movers
- 12/07/22
- What You Missed On Wall Street On Wednesday
- 01/20/23
- What You Missed On Wall Street This Morning
- 05/02/23
- What You Missed On Wall Street On Tuesday
- 05/02/23
- What You Missed On Wall Street This Morning
- 02/24/23
- Fly Intel: Pre-market Movers
- 05/09/23
- Fly Intel: After-Hours Movers
- 12/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/18/23
- Biotech Alert: Searches spiking for these stocks today
- 05/15/23
- Fly Intel: After-Hours Movers
- 03/08/23
- What You Missed On Wall Street On Wednesday
- 03/08/23
- What You Missed On Wall Street This Morning
- 05/26/23
- What You Missed On Wall Street On Friday
- 05/26/23
- What You Missed On Wall Street This Morning
- 05/26/23
- Fly Intel: Pre-market Movers
- 04/21/23
- What You Missed On Wall Street On Friday
- 02/24/23
- Four new option listings and one option delisting on February 24th
- 05/26/23
- Largest borrow rate increases among liquid names
- 05/24/23
- Largest borrow rate increases among liquid names
- 04/19/23
- Big Lots call volume above normal and directionally bullish
- 04/18/23
- Big Lots put volume heavy and directionally bearish
|
Recommendations
| ShowHide Related Items >><< - 05/30/23 Morgan Stanley
- Cooper Companies initiated with an Equal Weight at Morgan Stanley
- 05/24/23 Piper Sandler
- Cooper Companies price target raised to $430 from $375 at Piper Sandler
- 05/16/23 Stifel
- Cooper Companies price target raised to $420 from $380 at Stifel
- 05/15/23 Wells Fargo
- Cooper Companies price target raised to $430 from $355 at Wells Fargo
- 06/01/23
- Cooper Companies sees FY23 EPS, $12.66-$12.96, consensus $12.78
- 06/01/23
- Cooper Companies reports Q2 EPS $3.08 , consensus $3.03
- 03/02/23
- Cooper Companies sees FY23 EPS $12.60-$12.90, consensus $12.52
- 03/02/23
- Cooper Companies reports Q4 EPS $2.90, consensus $2.70
- 05/30/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/03/23
- What You Missed On Wall Street This Morning
- 12/22/22
- What You Missed On Wall Street On Thursday
- 12/22/22
- What You Missed On Wall Street This Morning
- 03/03/23
- Early notable gainers among liquid option names on March 3rd
|